SEC Form D · filed April 5, 2024
NovaBay Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Julie Garlikov · EMERYVILLE, CADirectorJustin M. Hall · EMERYVILLE, CAExecTommy Law · EMERYVILLE, CAExecPaul E. Freiman · EMERYVILLE, CADirectorSwan E. Sit · EMERYVILLE, CADirectorYenyou (Jeff) E. Zheng · EMERYVILLE, CADirectorYongxiang (Sean) Zheng · EMERYVILLE, CADirectorBhavika Vyas · New York, NYDirectorMijia (Bob) E. Wu · EMERYVILLE, CADirectorDax T. Mitchell · Dallas, TXExecJp A. Paquin · New York, NYDirectorStephen E. Butts · Chapel Hill, NCDirectorSamuel Schreiber · Chilmark, MADirectorJorge E. Bartolome · Chapel Hill, NCDirectorCato Partners GP, LLC · New York, NYDirectorCato Partners Management, LLC · New York, NYDirectorWilliam Burns · McKinney, TXExecSteven M. Diedrich · Waco, TXDirectorJerry L. Whitmire · Tempe, AZDirectorvan Biema Value Partners, LLC · New York, NYDirectorJeff Siegel · Huntsville, UTExecStephen Dalby · Lehi, UTDirectorHugh D. Evans · NEW YORK, NYDirectorVincent A. Levien · Florham Park, NJExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗